IL6 and obesity disorder: While MOTS-c treatment had no effect on the body weight of mice fed a normal diet, when administered to mice fed a HFD, it significantly decreased the rate of obesity and significantly reduced basal levels of circulating IL-6 and TNF-α associated with the pathogenesis of obesity and insulin resistance.